HK1139737A1 - Genetic analysis systems and methods - Google Patents
Genetic analysis systems and methodsInfo
- Publication number
- HK1139737A1 HK1139737A1 HK10106416.1A HK10106416A HK1139737A1 HK 1139737 A1 HK1139737 A1 HK 1139737A1 HK 10106416 A HK10106416 A HK 10106416A HK 1139737 A1 HK1139737 A1 HK 1139737A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- genetic analysis
- analysis systems
- systems
- genetic
- Prior art date
Links
- 238000012252 genetic analysis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/30—Data warehousing; Computing architectures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/40—Population genetics; Linkage disequilibrium
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Bioethics (AREA)
- Databases & Information Systems (AREA)
- Physiology (AREA)
- Ecology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86806606P | 2006-11-30 | 2006-11-30 | |
US95112307P | 2007-07-20 | 2007-07-20 | |
US11/781,679 US20080131887A1 (en) | 2006-11-30 | 2007-07-23 | Genetic Analysis Systems and Methods |
US97219807P | 2007-09-13 | 2007-09-13 | |
US98562207P | 2007-11-05 | 2007-11-05 | |
US98968507P | 2007-11-21 | 2007-11-21 | |
PCT/US2007/086138 WO2008067551A2 (en) | 2006-11-30 | 2007-11-30 | Genetic analysis systems and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1139737A1 true HK1139737A1 (en) | 2010-09-24 |
Family
ID=38962435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10106416.1A HK1139737A1 (en) | 2006-11-30 | 2010-06-30 | Genetic analysis systems and methods |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2102651A4 (en) |
JP (2) | JP2010522537A (en) |
KR (1) | KR20090105921A (en) |
CN (1) | CN103642902B (en) |
AU (1) | AU2007325021B2 (en) |
CA (1) | CA2671267A1 (en) |
GB (1) | GB2444410B (en) |
HK (1) | HK1139737A1 (en) |
TW (1) | TWI363309B (en) |
WO (1) | WO2008067551A2 (en) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8340950B2 (en) | 2006-02-10 | 2012-12-25 | Affymetrix, Inc. | Direct to consumer genotype-based products and services |
US20080131887A1 (en) | 2006-11-30 | 2008-06-05 | Stephan Dietrich A | Genetic Analysis Systems and Methods |
WO2008103299A2 (en) | 2007-02-16 | 2008-08-28 | Massachusetts Eye & Ear Infirmary | Methods and compositions for prognosing, detecting, and treating age-related macular degeneration |
US20080228699A1 (en) | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Creation of Attribute Combination Databases |
FR2934698B1 (en) * | 2008-08-01 | 2011-11-18 | Commissariat Energie Atomique | PREDICTION METHOD FOR THE PROGNOSIS OR DIAGNOSIS OR THERAPEUTIC RESPONSE OF A DISEASE AND IN PARTICULAR PROSTATE CANCER AND DEVICE FOR PERFORMING THE METHOD. |
GB2478065A (en) * | 2008-08-08 | 2011-08-24 | Navigenics Inc | Method and systems for personalized action plans |
US20100070455A1 (en) * | 2008-09-12 | 2010-03-18 | Navigenics, Inc. | Methods and Systems for Incorporating Multiple Environmental and Genetic Risk Factors |
NZ572036A (en) * | 2008-10-15 | 2010-03-26 | Nikola Kirilov Kasabov | Data analysis and predictive systems and related methodologies |
WO2010067381A1 (en) * | 2008-12-12 | 2010-06-17 | Decode Genetics Ehf | Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction |
US8108406B2 (en) | 2008-12-30 | 2012-01-31 | Expanse Networks, Inc. | Pangenetic web user behavior prediction system |
EP3276526A1 (en) | 2008-12-31 | 2018-01-31 | 23Andme, Inc. | Finding relatives in a database |
WO2010126614A2 (en) | 2009-04-30 | 2010-11-04 | Good Start Genetics, Inc. | Methods and compositions for evaluating genetic markers |
WO2010139006A1 (en) * | 2009-06-01 | 2010-12-09 | Genetic Technologies Limited | Methods for breast cancer risk assessment |
DE102010013114B4 (en) * | 2010-03-26 | 2012-02-16 | Rüdiger Lawaczeck | Prediagnostic safety system |
KR20110136638A (en) * | 2010-06-15 | 2011-12-21 | 재단법인 게놈연구재단 | Online social network construction method and system with personal genome data |
WO2012006669A1 (en) * | 2010-07-13 | 2012-01-19 | Fitgenes Pty Ltd | System and method for determining personal health intervention |
US20120078901A1 (en) * | 2010-08-31 | 2012-03-29 | Jorge Conde | Personal Genome Indexer |
US20120309641A1 (en) | 2010-10-19 | 2012-12-06 | Medtronic, Inc. | Diagnostic kits, genetic markers, and methods for scd or sca therapy selection |
CN103314383A (en) * | 2010-11-01 | 2013-09-18 | 皇家飞利浦电子股份有限公司 | In vitro diagnostic testing including automated brokering of royalty payments for proprietary tests |
US9163281B2 (en) | 2010-12-23 | 2015-10-20 | Good Start Genetics, Inc. | Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction |
US8718950B2 (en) | 2011-07-08 | 2014-05-06 | The Medical College Of Wisconsin, Inc. | Methods and apparatus for identification of disease associated mutations |
US20140310215A1 (en) * | 2011-09-26 | 2014-10-16 | John Trakadis | Method and system for genetic trait search based on the phenotype and the genome of a human subject |
WO2013055911A1 (en) | 2011-10-14 | 2013-04-18 | Dana-Farber Cancer Institute, Inc. | Znf365/zfp365 biomarker predictive of anti-cancer response |
KR101295785B1 (en) * | 2011-10-31 | 2013-08-12 | 삼성에스디에스 주식회사 | Apparatus and Method for Constructing Gene-Disease Relation Database |
US10437858B2 (en) | 2011-11-23 | 2019-10-08 | 23Andme, Inc. | Database and data processing system for use with a network-based personal genetics services platform |
US8209130B1 (en) | 2012-04-04 | 2012-06-26 | Good Start Genetics, Inc. | Sequence assembly |
KR20140009854A (en) * | 2012-07-13 | 2014-01-23 | 삼성전자주식회사 | Method and apparatus for analyzing gene information for treatment decision |
KR101967248B1 (en) * | 2012-08-16 | 2019-04-10 | 삼성전자주식회사 | Method and apparatus for analyzing personalized multi-omics data |
JP5844715B2 (en) * | 2012-11-07 | 2016-01-20 | 学校法人沖縄科学技術大学院大学学園 | Data communication system, data analysis apparatus, data communication method, and program |
KR101533395B1 (en) * | 2013-01-21 | 2015-07-08 | 이상열 | Method and system estimating resemblance between subject using single nucleotide polymorphism |
WO2014119914A1 (en) * | 2013-02-01 | 2014-08-07 | 에스케이텔레콤 주식회사 | Method for providing information about gene sequence-based personal marker and apparatus using same |
EP2971159B1 (en) | 2013-03-14 | 2019-05-08 | Molecular Loop Biosolutions, LLC | Methods for analyzing nucleic acids |
US20140274763A1 (en) * | 2013-03-15 | 2014-09-18 | Pathway Genomics Corporation | Method and system to predict response to pain treatments |
US9192647B2 (en) * | 2013-10-04 | 2015-11-24 | Hans-Michael Dosch | Method for reversing recent-onset type 1 diabetes (T1D) by administering substance P (sP) |
US10851414B2 (en) | 2013-10-18 | 2020-12-01 | Good Start Genetics, Inc. | Methods for determining carrier status |
TW201516725A (en) * | 2013-10-18 | 2015-05-01 | Tci Gene Inc | Single nucleotide polymorphism disease incidence prediction system |
FI20136079A (en) * | 2013-11-04 | 2015-05-05 | Medisapiens Oy | Genetic health assessment procedure and system |
DE202014010499U1 (en) | 2013-12-17 | 2015-10-20 | Kymab Limited | Targeting of human PCSK9 for cholesterol treatment |
KR101400946B1 (en) * | 2013-12-27 | 2014-05-29 | 한국과학기술정보연구원 | Biological network analyzing device and method thereof |
KR102131973B1 (en) * | 2013-12-30 | 2020-07-08 | 주식회사 케이티 | Method and System for personalized healthcare |
CN106460062A (en) | 2014-05-05 | 2017-02-22 | 美敦力公司 | Methods and compositions for SCD, CRT, CRT-D, or SCA therapy identification and/or selection |
WO2015175530A1 (en) | 2014-05-12 | 2015-11-19 | Gore Athurva | Methods for detecting aneuploidy |
EP4328245A3 (en) | 2014-07-15 | 2024-06-05 | Kymab Ltd. | Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations |
DE202015009007U1 (en) | 2014-07-15 | 2016-08-19 | Kymab Limited | Targeting of human PCSK9 for cholesterol treatment |
EP3332790A1 (en) | 2014-07-15 | 2018-06-13 | Kymab Limited | Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations |
WO2016023916A1 (en) | 2014-08-12 | 2016-02-18 | Kymab Limited | Treatment of disease using ligand binding to targets of interest |
WO2016035168A1 (en) * | 2014-09-03 | 2016-03-10 | 大塚製薬株式会社 | Pathology determination assistance device, method, program and storage medium |
US11408024B2 (en) | 2014-09-10 | 2022-08-09 | Molecular Loop Biosciences, Inc. | Methods for selectively suppressing non-target sequences |
US10429399B2 (en) | 2014-09-24 | 2019-10-01 | Good Start Genetics, Inc. | Process control for increased robustness of genetic assays |
WO2016071701A1 (en) | 2014-11-07 | 2016-05-12 | Kymab Limited | Treatment of disease using ligand binding to targets of interest |
US10066259B2 (en) | 2015-01-06 | 2018-09-04 | Good Start Genetics, Inc. | Screening for structural variants |
CA2974199A1 (en) | 2015-01-20 | 2016-07-28 | Nantomics, Llc | Systems and methods for response prediction to chemotherapy in high grade bladder cancer |
CA2975529A1 (en) * | 2015-02-09 | 2016-08-18 | 10X Genomics, Inc. | Systems and methods for determining structural variation and phasing using variant call data |
CA2978708A1 (en) * | 2015-03-03 | 2016-09-09 | Nantomics, Llc | Ensemble-based research recommendation systems and methods |
KR102508971B1 (en) * | 2015-07-22 | 2023-03-09 | 주식회사 케이티 | Method and apparatus for predicting the disease risk |
JP2018536914A (en) * | 2015-09-16 | 2018-12-13 | グッド スタート ジェネティクス, インコーポレイテッド | Systems and methods for genetic medicine testing |
AU2016324166A1 (en) * | 2015-09-18 | 2018-05-10 | Omicia, Inc. | Predicting disease burden from genome variants |
KR101795662B1 (en) * | 2015-11-19 | 2017-11-13 | 연세대학교 산학협력단 | Apparatus and Method for Diagnosis of metabolic disease |
FR3045874B1 (en) * | 2015-12-18 | 2019-06-14 | Axlr, Satt Du Languedoc Roussillon | ARCHITECTURE FOR GENOMIC DATA ANALYSIS |
JP6776576B2 (en) * | 2016-03-28 | 2020-10-28 | 富士通株式会社 | Database processing program, database processing device and database processing method |
KR101991007B1 (en) * | 2016-05-27 | 2019-06-20 | (주)메디젠휴먼케어 | A system and apparatus for disease-related genomic analysis using SNP |
JP7036749B6 (en) * | 2016-06-29 | 2022-05-30 | コーニンクレッカ フィリップス エヌ ヴェ | Disease-oriented genome anonymization |
KR101815529B1 (en) | 2016-07-29 | 2018-01-30 | (주)신테카바이오 | Human Haplotyping System And Method |
WO2018042185A1 (en) * | 2016-09-02 | 2018-03-08 | Imperial Innovations Ltd | Methods, systems and apparatus for identifying pathogenic gene variants |
CN106778083A (en) * | 2016-11-28 | 2017-05-31 | 墨宝股份有限公司 | A kind of method and device for automatically generating genetic test report |
EP3553737A4 (en) * | 2016-12-12 | 2019-11-06 | Nec Corporation | Information processing device, genetic information creation method, and program |
JP7264046B2 (en) * | 2017-03-15 | 2023-04-25 | 東洋紡株式会社 | Genetic test method and genetic test kit |
CN108629153A (en) * | 2017-03-23 | 2018-10-09 | 广州康昕瑞基因健康科技有限公司 | Cma gene analysis method and system |
JP7414281B2 (en) * | 2017-08-08 | 2024-01-16 | クイーンズランド ユニバーシティ オブ テクノロジー | How to diagnose early heart failure |
KR102073590B1 (en) * | 2017-08-17 | 2020-02-06 | (주)에이엔티홀딩스 | Method, system and non-transitory computer-readable recording medium for providing a service based on genetic information |
KR102097540B1 (en) * | 2017-12-26 | 2020-04-07 | 주식회사 클리노믹스 | Method for disease and phenotype risk score calculation |
CN108549795A (en) * | 2018-03-13 | 2018-09-18 | 刘吟 | Genetic counselling information system based on pedigree chart frame |
GB201810897D0 (en) * | 2018-07-03 | 2018-08-15 | Chronomics Ltd | Phenotype prediction |
CN109355368A (en) * | 2018-10-22 | 2019-02-19 | 江苏美因康生物科技有限公司 | A kind of kit and method of quick detection hypertension individuation medication gene pleiomorphism |
EP3874510A4 (en) | 2018-10-31 | 2022-08-03 | Ancestry.com DNA, LLC | Estimation of phenotypes using dna, pedigree, and historical data |
GB2578727A (en) * | 2018-11-05 | 2020-05-27 | Earlham Inst | Genomic analysis |
JP2022515226A (en) * | 2018-12-20 | 2022-02-17 | ザ・ジョンズ・ホプキンス・ユニバーシティ | Detection / processing configuration and method |
JP7137520B2 (en) * | 2019-04-23 | 2022-09-14 | ジェネシスヘルスケア株式会社 | How to determine the risk of pancreatitis |
JP7137525B2 (en) * | 2019-04-24 | 2022-09-14 | ジェネシスヘルスケア株式会社 | How to determine the risk of contact dermatitis |
JP7137524B2 (en) * | 2019-04-24 | 2022-09-14 | ジェネシスヘルスケア株式会社 | Methods for determining risk of knee osteoarthritis |
JP7137521B2 (en) * | 2019-04-24 | 2022-09-14 | ジェネシスヘルスケア株式会社 | How to determine your risk of psoriasis |
JP7137523B2 (en) * | 2019-04-24 | 2022-09-14 | ジェネシスヘルスケア株式会社 | How to determine your risk of hives |
JP7137526B2 (en) * | 2019-04-24 | 2022-09-14 | ジェネシスヘルスケア株式会社 | Methods for determining the risk of atopic dermatitis |
JP7137522B2 (en) * | 2019-04-24 | 2022-09-14 | ジェネシスヘルスケア株式会社 | How to determine your scoliosis risk |
KR102357453B1 (en) * | 2019-06-24 | 2022-02-04 | (주) 아이크로진 | Service method and platform for visualizing using a gene information |
KR102091790B1 (en) * | 2019-09-02 | 2020-03-20 | 주식회사 클리노믹스 | System for providng genetic zodiac sign using genetic information between examinees and organisms |
KR102151716B1 (en) * | 2019-12-06 | 2020-09-04 | 주식회사 클리노믹스 | System for providing gemetic surmane information using genomic information |
KR102179850B1 (en) * | 2019-12-06 | 2020-11-17 | 주식회사 클리노믹스 | System and method for predicting health using analysis device for intraoral microbes (bacteria, virus, viroid, and/or fungi) |
KR102136207B1 (en) * | 2019-12-31 | 2020-07-21 | 주식회사 클리노믹스 | Sytem for providing personalized social contents imformation based on genetic information and method thereof |
KR102138165B1 (en) * | 2020-01-02 | 2020-07-27 | 주식회사 클리노믹스 | Method for providing identity analyzing service using standard genome map database by nationality, ethnicity, and race |
KR102223362B1 (en) * | 2020-08-10 | 2021-03-05 | 주식회사 쓰리빌리언 | System and method to identify disease associated genetic variants by using symptom associated genetic variants relationship |
KR102223361B1 (en) * | 2020-09-23 | 2021-03-05 | 주식회사 쓰리빌리언 | System for diagnosing genetic disease using gene network |
CN113921143B (en) * | 2021-10-08 | 2024-04-16 | 天津金域医学检验实验室有限公司 | Personalized estimation method and system for Bayes factors in coseparation analysis |
CN114360732B (en) * | 2022-01-12 | 2024-04-09 | 平安科技(深圳)有限公司 | Medical data analysis method, device, electronic equipment and storage medium |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000067139A (en) * | 1998-08-25 | 2000-03-03 | Hitachi Ltd | Electronic medical sheet system |
WO2001016860A2 (en) * | 1999-08-27 | 2001-03-08 | Iris Bio Technologies, Inc. | Artificial intelligence system for genetic analysis |
AU1367201A (en) * | 1999-10-01 | 2001-05-10 | Orchid Biosciences, Inc. | Method and system for providing genotype clinical information over a computer network |
US20030208454A1 (en) * | 2000-03-16 | 2003-11-06 | Rienhoff Hugh Y. | Method and system for populating a database for further medical characterization |
JP2002107366A (en) * | 2000-10-02 | 2002-04-10 | Hitachi Ltd | Diagnosis-assisting system |
WO2002063415A2 (en) * | 2000-12-04 | 2002-08-15 | Genaissance Pharmaceuticals, Inc. | System and method for the management of genomic data |
US20020128860A1 (en) * | 2001-01-04 | 2002-09-12 | Leveque Joseph A. | Collecting and managing clinical information |
US20020187483A1 (en) * | 2001-04-20 | 2002-12-12 | Cerner Corporation | Computer system for providing information about the risk of an atypical clinical event based upon genetic information |
US7461006B2 (en) * | 2001-08-29 | 2008-12-02 | Victor Gogolak | Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data |
US20030108938A1 (en) * | 2001-11-06 | 2003-06-12 | David Pickar | Pharmacogenomics-based clinical trial design recommendation and management system and method |
US20040053263A1 (en) * | 2002-08-30 | 2004-03-18 | Abreu Maria T. | Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
JPWO2004109551A1 (en) * | 2003-06-05 | 2006-07-20 | 株式会社日立ハイテクノロジーズ | Information providing system and program using base sequence related information |
GB0313964D0 (en) * | 2003-06-16 | 2003-07-23 | Mars Inc | Genotype test |
US7084264B2 (en) * | 2003-07-16 | 2006-08-01 | Chau-Ting Yeh | Viral sequences |
US8222005B2 (en) * | 2003-09-17 | 2012-07-17 | Agency For Science, Technology And Research | Method for gene identification signature (GIS) analysis |
JP5235274B2 (en) * | 2003-10-15 | 2013-07-10 | 株式会社サインポスト | Method and apparatus for determining disease risk |
US20050214811A1 (en) * | 2003-12-12 | 2005-09-29 | Margulies David M | Processing and managing genetic information |
US7127355B2 (en) * | 2004-03-05 | 2006-10-24 | Perlegen Sciences, Inc. | Methods for genetic analysis |
US20070265217A1 (en) * | 2004-07-16 | 2007-11-15 | Bayer Healthcare Ag | Single Nucleotide Polymorphisms as Prognostic Tool to Diagnose Adverse Drug Reactions (Adr) and Drug Efficacy |
AU2005305765A1 (en) * | 2004-11-19 | 2006-05-26 | Oy Jurilab Ltd | Method and kit for detecting a risk of essential arterial hypertension |
-
2007
- 2007-11-30 CN CN201310565723.1A patent/CN103642902B/en active Active
- 2007-11-30 JP JP2009539519A patent/JP2010522537A/en active Pending
- 2007-11-30 GB GB0723512A patent/GB2444410B/en active Active
- 2007-11-30 TW TW096145856A patent/TWI363309B/en not_active IP Right Cessation
- 2007-11-30 AU AU2007325021A patent/AU2007325021B2/en not_active Ceased
- 2007-11-30 WO PCT/US2007/086138 patent/WO2008067551A2/en active Application Filing
- 2007-11-30 CA CA002671267A patent/CA2671267A1/en not_active Abandoned
- 2007-11-30 KR KR1020097013756A patent/KR20090105921A/en not_active Application Discontinuation
- 2007-11-30 EP EP07854875A patent/EP2102651A4/en not_active Ceased
-
2010
- 2010-06-30 HK HK10106416.1A patent/HK1139737A1/en not_active IP Right Cessation
-
2014
- 2014-05-16 JP JP2014102062A patent/JP2014140387A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20090105921A (en) | 2009-10-07 |
TWI363309B (en) | 2012-05-01 |
GB2444410B (en) | 2011-08-24 |
EP2102651A2 (en) | 2009-09-23 |
CN103642902B (en) | 2016-01-20 |
WO2008067551A3 (en) | 2008-12-11 |
WO2008067551A2 (en) | 2008-06-05 |
CN103642902A (en) | 2014-03-19 |
TW200847056A (en) | 2008-12-01 |
JP2010522537A (en) | 2010-07-08 |
AU2007325021B2 (en) | 2013-05-09 |
JP2014140387A (en) | 2014-08-07 |
GB2444410A (en) | 2008-06-04 |
GB0723512D0 (en) | 2008-01-09 |
CA2671267A1 (en) | 2008-06-05 |
EP2102651A4 (en) | 2010-11-17 |
AU2007325021A1 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1139737A1 (en) | Genetic analysis systems and methods | |
ZA200903761B (en) | Genetic analysis systems and methods | |
EP2030011A4 (en) | Systems and methods for analyzing nanoreporters | |
EP2126702A4 (en) | System analysis and management | |
GB2479662B (en) | Well control systems and associated methods | |
GB201109817D0 (en) | System and method | |
EP2043519A4 (en) | Lameness evaluation systems and methods | |
EP1986735A4 (en) | Systems and methods for volume reduction | |
EP2074577A4 (en) | Payment systems and methods | |
IL192759A0 (en) | New method and system | |
GB2439644B (en) | Input evaluation system and input evaluation method | |
EP1976782A4 (en) | Systems and methods for diverting objects | |
EP1977359A4 (en) | Methods and systems for conducting research operations | |
IL197284A0 (en) | Disinfectant systems and methods | |
EP2029964A4 (en) | Systems and methods for illuminating materials | |
ZA200906118B (en) | Descenting systems and methods | |
GB2441091B (en) | Methods and systems for putting analysis | |
EP2142660A4 (en) | Methods and systems for o-glycosylating proteins | |
GB0618030D0 (en) | Advisory systems and methods | |
ZA200806800B (en) | Systems and methods for diverting objects | |
TWI319540B (en) | Interaction system and method | |
EP2092480A4 (en) | Trading system and method | |
EP2020167A4 (en) | Generic electromagnetically-countered systems and methods | |
GB0623059D0 (en) | Database system and method | |
GB0909190D0 (en) | Oilfield analysis system and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20171130 |